A comprehensive study of the direct and indirect costs of adult asthma.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Allergy and Clinical Immunology

• Publication date

  2003-06-01

• Fields of study

  Medicine, Economics

• Identifiers
  DOI 10.1067/MAI.2003.1449PMID 12789219
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Costs of asthma are correlated with severity: a 1-yr prospective study

  2002cited by this paper
• Guidelines for School Programs to Prevent Skin Cancer

  2002cited by this paper
• Costs of occupational COPD and asthma.

  2002cited by this paper
• A national study of medical care expenditures for respiratory conditions

  2002cited by this paper
• [Epidemiology and costs of bronchial asthma and chronic bronchitis in Germany].

  2001cited by this paper
• Health Care Utilization and Cost in Children with Asthma and Selected Comorbidities

  2001cited by this paper
• Costs of asthma treatment in Estonia.

  2001cited by this paper
• Epidemiologie und Kosten von Asthma bronchiale und chronischer Bronchitis in Deutschland

  2001cited by this paper
• The health economics of asthma and rhinitis. I. Assessing the economic impact.

  2001cited by this paper
• Original Articles Prospective Study of the Patient-Level Cost of Asthma Care in Children

  2001cited by this paper
• Asthma prevalence, cost, and adherence with expert guidelines on the utilization of health care services and costs in a state Medicaid population.

  2001cited by this paper
• Direct and indirect costs of asthma to an employer.

  2000cited by this paper
• [Economic study on asthma in Mexico].

  2000cited by this paper
• Risk factors for hospitalization among adults with asthma: the influence of sociodemographic factors and asthma severity

  2000cited by this paper
• Systemic antifungal drugs.

  2000cited by this paper
• Correction to the scientific record.

  2000cited by this paper
• Risk factors and costs associated with an asthma attack

  2000cited by this paper
• Trends in the cost of illness for asthma in the United States, 1985-1994.

  2000cited by this paper
• Asthma: an analysis of high-cost patients.

  2000cited by this paper
• Drugs for asthma.

  2000cited by this paper
• Determinants of health care costs and patterns of care of asthmatic patients in Switzerland.

  2000cited by this paper
• Un estudio económico sobre asma en México

  2000cited by this paper
• The economic cost of asthma in Singapore.

  1999cited by this paper
• Health Care Costs Associated with Acute Asthma: A Prospetive Economic Analysis

  1999cited by this paper
• Health care costs associated with acute asthma: a prospective economic analysis.

  1999cited by this paper
• The economic burden of asthma in US children: estimates from the National Medical Expenditure Survey.

  1999cited by this paper
• Mometasone furoate nasal spray for allergic rhinitis.

  1999cited by this paper
• Health-care costs of inner-city patients with asthma.

  1999cited by this paper
• Asthma's impact on society : the social and economic burden

  1999cited by this paper
• The cost of asthma in the emergency department and hospital.

  1999cited by this paper
• Cefdinir--a new oral cephalosporin.

  1998cited by this paper
• Costs of asthma according to the degree of severity.

  1998cited by this paper
• Determinants of managed care penetration.

  1998cited by this paper
• Assessment of asthma severity in adults with asthma treated by family practitioners, allergists, and pulmonologists.

  1998cited by this paper
• Health care utilization and cost among children with asthma who were enrolled in a health maintenance organization.

  1997cited by this paper
• A national estimate of the economic costs of asthma.

  1997cited by this paper
• Systemic antifungal drugs.

  1997cited by this paper
• Cetirizine--a new antihistamine.

  1996cited by this paper
• Direct and indirect costs of asthma in Canada, 1990.

  1996cited by this paper
• Asthma, employment status, and disability among adults treated by pulmonary and allergy specialists.

  1996cited by this paper
• Acrivastine/pseudoephedrine (Semprex-D) for seasonal allergic rhinitis.

  1994cited by this paper
• An economic evaluation of asthma in the United States.

  1992cited by this paper
• Clinical markers of asthma severity and risk: importance of subjective as well as objective factors.

  1992cited by this paper
• The cost of asthma in New South Wales

  1991cited by this paper
• Statistical abstract of the United States

  1978cited by this paper
• Lung biology in health and disease

  1977cited by this paper
• Statistical methods for rates and proportions

  1973cited by this paper

• Exacerbation-related burden in patients with severe asthma in South Korea: a population-based cohort study

  2026cites this paper
• Generation and preclinical assessment of depemokimab, an enhanced IL-5 antagonist monoclonal antibody

  2026cites this paper
• Evolution and factors associated with presenteeism in severe asthma after treatment with biologics.

  2025cites this paper
• Impact de l’asthme sur le travail : une revue de la littérature

  2025cites this paper
• The Economic Burden of Rheumatoid Arthritis in Low- and Middle-Income Countries: Systematic Review and Meta-Analysis.

  2025cites this paper
• Safety and Tolerability of Twice-Yearly Depemokimab in Patients with Asthma and Chronic Rhinosinusitis with Nasal Polyps: Pooled Results from SWIFT-1/-2 and ANCHOR-1/-2

  2025cites this paper
• Astım Hastalığının Küresel Ekonomik Yükü: Sistematik Derleme ve Meta Analiz Çalışması

  2025cites this paper
• Technological and digital innovations in improving adherence to asthma medication therapy

  2025cites this paper
• Assessing the Impact of Asthma: A Cross-Sectional Study in Workers Undergoing Therapy

  2025cites this paper
• Health loss and economic burden of asthma in China: a qualitative review based on existing literature

  2025cites this paper
• Current biological therapies for bronchial asthma

  2025cites this paper
• Epidemiology of patients with severe asthma in Japan: a nationwide descriptive study

  2024cites this paper
• Predictors and components of inpatient asthma hospital cost: A retrospective cohort study. Analysis from a sample of 14 Belgian hospitals

  2024cites this paper
• Estimating the cost of asthma: moderating effect of race/ethnicity on the relationship between asthma severity and the direct cost

  2024cites this paper
• Expert Consensus on Oral Corticosteroids Stewardship for the Treatment of Severe Asthma in the Middle East and Africa.

  2024cites this paper
• Novel Machine Learning Identifies Five Asthma Phenotypes Using Cluster Analysis of Real-World Data.

  2024cites this paper
• Clinical characteristics of obese, fixed airway obstruction, exacerbation-prone phenotype and comorbidities among severe asthma patients: a single-center study

  2024cites this paper
• Exploring the cost-effectiveness of EBV vaccination to prevent multiple sclerosis in an Australian setting

  2023cites this paper
• Economic evaluation of biological treatments in patients with severe asthma: a systematic review

  2023cites this paper
• Toward a better understanding of severe asthma phenotypes in Latin America: results from the PREPARE study

  2023cites this paper
• Medical resource utilization and the associated costs of asthma in China: a 1-year retrospective study

  2023cites this paper
• Patterns of allergic sensitization in adults with severe asthma: the ATLAS non-interventional study

  2023cites this paper
• Impacto econômico pela exposição ao mofo habitacional nos casos de asma no Brasil

  2023cites this paper
• Đánh giá mức độ tiêu thụ thuốc điều trị hen phế quản ngoại trú: Nghiên cứu tại Bệnh viện tuyến quận Thành phố Hồ Chí Minh

  2023cites this paper
• PRevalence of the Eosinophilic Phenotype Among SeveRE asthma patients in Lebanon: results of the PREPARE study

  2023cites this paper
• Strong and graded associations between level of asthma severity and all-cause hospital care use and costs in the UK

  2023cites this paper
• Poor Translatability of Biomedical Research Using Animals — A Narrative Review

  2023cites this paper
• PHÂN TÍCH CHI PHÍ ĐIỀU TRỊ HEN PHẾ QUẢN CỦA NGƯỜI BỆNH THAM GIA CHƯƠNG TRÌNH QUẢN LÝ HEN NGOẠI TRÚ TẠI BỆNH VIỆN QUẬN 11 TRÊN QUAN ĐIỂM NGƯỜI CHI TRẢ

  2022cites this paper
• Severe asthma exacerbation rates are increased among female, Black, Hispanic, and younger adult patients: results from the US CHRONICLE study

  2022cites this paper
• The CRTh2 polymorphism rs533116 G > A associates with asthma severity in older females

  2022cites this paper
• Asthma burden according to treatment steps in the French population-based cohort CONSTANCES.

  2022cites this paper
• The Perceptions of Healthcare Students toward the Evidence-Based Practice of Asthma Management

  2021cites this paper
• Economic burden of asthma in Singapore

  2021cites this paper
• Clinical and economic consequences of switching from omalizumab to mepolizumab in uncontrolled severe eosinophilic asthma

  2021cites this paper
• Cost-effectiveness analysis of extended extracorporeal membrane oxygenation duration in newborns with congenital diaphragmatic hernia in the United States.

  2021cites this paper
• Economic impact of pharmacists' interventions in asthma management: a systematic review

  2021cites this paper
• Work absence in patients with asthma and/or COPD: a population-based study

  2021cites this paper
• Interaction effects of asthma and rhinitis control on work productivity and activity impairment: A cross-sectional study.

  2021cites this paper
• Direct and Indirect Costs of Asthma Burden in Abu Dhabi: A Retrospective Analysis of Insurance Claims Data from 2015 to 2018

  2021cites this paper
• Direct and Indirect Cost Savings From Sexually Transmitted Infection Testing, Treatment, and Counseling Among Foster Youth

  2021cites this paper
• Direct medical costs of pediatric asthma exacerbations requiring hospital attendance in a middle-income country.

  2020cites this paper
• Burden and socioeconomics of asthma, allergic rhinitis, atopic dermatitis and food allergy

  2020cites this paper
• Medical Costs and Productivity Loss Due to Mild, Moderate, and Severe Asthma in the United States

  2020cites this paper
• Asthma and fixed airflow obstruction: Long‐term trajectories suggest distinct endotypes

  2020cites this paper
• Increasing Prevalence and Mortality of Asthma With Age in Korea, 2002–2015: A Nationwide, Population-Based Study

  2020cites this paper
• The impact of budesonide inhalation suspension for asthma hospitalization: In terms of length of stay, recovery time from symptoms, and hospitalization costs.

  2020cites this paper
• Clinical and Economic Consequences of Switching From Omalizumab to Mepolizumab in Uncontrolled Severe Eosinophilic Asthma: an Observational Retrospective Study

  2020cites this paper
• Do Statins Improve Outcomes in Patients With Asthma on Inhaled Corticosteroid Therapy ? A Retrospective Analysis of the Mississippi Medicaid Database 2002-2004

  2019cites this paper
• Anti-interleukin-5 therapy (mepolizumab) in life-threatening asthma attack: A case-based discussion

  2019cites this paper
• Asthma impacts on workplace productivity in employed patients who are symptomatic despite background therapy: a multinational survey

  2019cites this paper
• The Disproportionate Burden Of Asthma By Race, Sex, Income And Education

  2019cites this paper
• Bronchial Thermoplasty.

  2019cites this paper
• Asthma Medication Prescribing Practices in Pediatric Office Visits

  2019cites this paper
• The Prevalence, Characteristics, and Patient Burden of Severe Asthma Determined by Using a Japan Health Care Claims Database.

  2019cites this paper
• Omalizumab and long-term quality of life outcomes in patients with moderate-to-severe allergic asthma: a systematic review

  2019cites this paper
• Heterogeneity in Severe Asthma

  2019cites this paper
• Cost-effectiveness of implementing objective diagnostic verification of asthma in the United States.

  2019cites this paper
• Exacerbation Patterns in Adults with Asthma in England. A Population‐based Study

  2019cites this paper
• Direct and indirect costs associated with moderate and severe asthma in Quebec, Canada

  2019cites this paper
• The Burden of Severe Asthma in France: A Case-Control Study Using a Medical Claims Database.

  2019cites this paper
• The Economic Burden of Asthma in Greece: A Cross-Sectional Study

  2019cites this paper
• Evaluating Direct Costs and Productivity Losses of Asthma Patients Receiving GINA 4/5 Therapy in the US.

  2019cites this paper
• Effect of genetic variation on healthcare outcomes in children and adults with eczema and asthma

  2018cites this paper
• Age and gender relationships with systemic corticosteroid induced morbidity in asthma: A cross- 1 sectional population-based study of computerised medical records

  2018cites this paper
• Age and Sex Associations with Systemic Corticosteroid-Induced Morbidity in Asthma.

  2018cites this paper
• Diagnostic significance of serum periostin in eosinophilic chronic sinusitis with nasal polyps

  2018cites this paper
• Economic Burden of Pediatric Asthma: Annual Cost of Disease in Iran

  2018influential citation
• Disease burden and productivity cost of chronic rhinosinusitis patients referred to a tertiary centre in Australia

  2018cites this paper
• Bronchial Thermoplasty: A Nonpharmacologic Therapy for Severe Asthma.

  2018cites this paper
• Asthma: definition, severity and impact of pulmonary exacerbations

  2017cites this paper
• The economic burden of adult asthma in Cyprus; a prevalence-based cost of illness study

  2017cites this paper
• A Structured Approach to Specialist-referred Difficult Asthma Patients Improves Control of Comorbidities and Enhances Asthma Outcomes.

  2017cites this paper
• Allergic rhinitis, atopic dermatitis, and asthma are associated with differences in school performance among Korean adolescents

  2017cites this paper
• Which Asthmatic Patients Should be Selected for Bronchial Thermoplasty

  2017cites this paper
• A Comparison of the Effects of Diaphragmatic Breathing Exercises and Yoga Pranayama Techniques on Pulmonary Function in Individuals with Exercise Induced Asthma

  2017cites this paper
• Asthma costs and social impact

  2017cites this paper
• Mepolizumab for the treatment of severe eosinophilic asthma

  2017cites this paper
• The surveillance system, diagnosis and treatment challenges of asthma and health policy orientation of main challenges.

  2017cites this paper
• Economic analysis of the phase III MENSA study evaluating mepolizumab for severe asthma with eosinophilic phenotype

  2017cites this paper
• Economic Valuation of Selected Illnesses in Environmental Public Health Tracking

  2017cites this paper
• Patient Characteristics and Individualization of Biologic Therapy.

  2017cites this paper
• Current Management of Severe Refractory Asthma in Italy: Analysis of Real-World Data

  2017cites this paper
• The Estimation and Inclusion of Presenteeism Costs in Applied Economic Evaluation: A Systematic Review.

  2017cites this paper
• Pharmacoeconomics of Biologic Therapy.

  2017cites this paper
• Les coûts directs liés aux soins de santé associés à l ’ asthme en Colombie-Britannique

  2016influential citation
• Survey of physicians’ attitudes toward the use of magnesium sulfate for acute asthma exacerbations in Turkey

  2016cites this paper
• Cost-Effectiveness of Asthma Step-Up Therapy as an Increased Dose of Extrafine-Particle Inhaled Corticosteroid or Add-On Long-Acting Beta2-Agonist

  2016cites this paper
• Impact of Age and Sex on Outcomes and Hospital Cost of Acute Asthma in the United States, 2011-2012

  2016cites this paper
• The role of autophagy in allergic inflammation: a new target for severe asthma

  2016cites this paper
• Clinical usefulness of mepolizumab in severe eosinophilic asthma

  2016cites this paper
• Asthma and asthma-related health care utilization among people without disabilities and people with physical disabilities.

  2016cites this paper
• Bronchial thermoplasty: a review of the evidence.

  2016cites this paper
• Chronic Rhinosinusitis: Epidemiology and Burden of Disease

  2016cites this paper
• Comparison of Health Care Utilization and Costs for Patients with Asthma by Severity and Health Insurance in Thailand.

  2016cites this paper
• Advances in Bronchial Thermoplasty.

  2016cites this paper
• Economic Burden of Illness Among Patients with Severe Asthma in a Managed Care Setting

  2016cites this paper
• Costs Attributable to Overweight and Obesity in Working Asthma Patients in the United States

  2016cites this paper
• Effectiveness of Interventions to Teach Metered-Dose and Diskus Inhaler Techniques. A Randomized Trial.

  2016cites this paper
• Meteorological conditions, climate change, new emerging factors, and asthma and related allergic disorders. A statement of the World Allergy Organization

  2015cites this paper
• Medico-social aspects of patients with bronchial asthma

  2015cites this paper